| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 37,529 | 36,377 | 34,965 | 44,041 | | Cost of Revenue | 27,546 | 27,265 | 25,419 | 31,643 | | | Gross Profit | 9,983 | 9,112 | 9,546 | 12,398 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,206 | 3,396 | 3,573 | 4,060 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,777 | 5,716 | 5,973 | 8,338 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 119 | 128 | 81 | 170 | | Earnings Before Interest And Taxes | 6,896 | 5,844 | 6,054 | 8,508 | | Interest Expense | 1 |
-
| 1 | 1 | | Income Before Tax | 6,895 | 5,844 | 6,053 | 8,507 | | Income Tax Expense | 2,731 | 2,326 | 2,409 | 3,258 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,164 | 3,518 | 3,644 | 5,249 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,164 | 3,518 | 3,644 | 5,249 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,164 | $3,518 | $3,644 | $5,249 |
|
1.52% Nasdaq 0.00%
Income Statement
